Heart Pump Device Market is expected to reach USD 5.5 billion by 2026 with CAGR of 21.6%

 According to the new market research report "Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2026", published by MarketsandMarkets™, the Heart Pump Device Market is projected to reach USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026.


Browse in-depth TOC on "Heart Pump Device Market"

132 – Tables

38 – Figures

179 – Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237125725

The growth of this market is driven by increasing investments, funds, and grants for research on heart failure treatment; rising prevalence of cardiovascular diseases; long waiting periods for heart transplants; favorable reimbursements for heart pump devices; and increasing obesity.

Ventricular assist devices are expected to hold the largest share of the heart pump device market, by product in 2021.

Based on products, the heart pump devices market is segmented into ventricular assist devices, intra- aortic balloon pumps, and total artificial hearts. Ventricular assist devices are the largest and fastest-growing segment in this market. Growth in this segment can primarily be attributed to technological advancements, the shortage of organ donors, and the increasing prevalence of heart failure globally.

Implantable heart pump devices are expected to hold the largest share of the heart pump device market, by type in 2021.

Based on type, the market is segmented into implantable heart pump devices and extracorporeal heart pump devices. In 2020, implantable heart pump devices accounted for the largest share of this market, due to the introduction of innovative products by leading players and the rising need for an efficient solution to manage heart failure.

Bridge-to-transplant is expected to hold the largest share of the heart pump device market, by therapy in 2021.

Based on therapy, the market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and other therapies. In 2020, the BTT segment accounted for the largest share of this market. Growing awareness about transplantation and the availability of VADs for BTT have propelled the growth of this segment.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=237125725

Europe commanded the largest share of the heart pump device market in 2021.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, Europe commanded the largest share of the market. The large share of this market segment can be attributed to the rising adoption of heart pump devices, the high prevalence of CVDs, the growing number of research activities to improve current technologies, and the limited availability of donor hearts for transplants.

The major players operating in this heart pump device market are Abbott Laboratories (US), Abiomed (US), Medtronic (Ireland), Teleflex Incorporated (US), SynCardia Systems (US), Fresenius Medical Care AG & Co. KGaA (Germany), Getinge (Sweden), CardiacAssist, Inc. (US), Berlin Heart (Germany), Jarvik Heart, Inc. (US), CARMAT (France), SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. (Japan), Angiodroid (Italy), CardioDyme (US), and World Heart Corporation (US).

Speak to Analyst:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=237125725

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Related Reports:

Interventional Cardiology Devices Market:

https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

Vascular Closure Device Market:

https://www.marketsandmarkets.com/Market-Reports/vascular-closure-device-market-180101468.html

European Medical Devices Market:

https://www.marketsandmarkets.com/Market-Reports/european-medical-devices-market-241277169.html

Bioabsorbable Stent Market:

https://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html

Pediatric Interventional Cardiology Market:

https://www.marketsandmarkets.com/Market-Reports/pediatric-interventional-cardiology-market-236831456.html

Comments

Post a Comment

Popular posts from this blog

Urology Devices Industry worth $48.6 billion by 2028

 The global urology devices market , valued at US$32.6 billion in 2022, is forecasted to grow at a robust CAGR of 7.3%, reaching US$34.1 billion in 2023 and an impressive US$48.6 billion by 2028. Investments by hospitals in procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices. Moreover, increased demand for MIS robotic systems is expected to increase in the coming years, which is expected to propel the market growth. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Browse in-depth TOC on “Urology Devices Market” 159 — Tables 44 — Figures 274 — Pages In 2022, the instruments segment held the largest share of the urology devices market by product segment. The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022....
Read more

Healthcare Simulation Market worth $4.6 billion by 2028

Image
The global healthcare simulation market is projected to reach USD 4.6 billion by 2028 from USD 2.2 billion in 2023, at a high CAGR of 15.7% during the forecast period. The market's expansion is fuelled by an advancement in technology, such as high-fidelity manikins and virtual reality that have enhanced the realism and effectiveness of simulation training, for instance, high-fidelity simulators like Apollo (by Elevate Healthcare (formerly CAE)) and Nursing Anne Simulator (by Laerdal Medical) accelerates learning, reduces training time, and improves debriefing with automated patient responses; the growing complexity of modern medical procedures which requires training solutions offered by simulation. Further, the increasing number of medical schools is also propelling this market. For instance, according to Ministry of Health and Family Welfare, in India, the number of medical colleges has risen by 82%, from 387 before 2014 to 706 for the year 2024. Healthcare Simulation Market – G...
Read more

Bronchoscopy Market Size Worth USD 3.7 billion By 2027 | CAGR: 7.9%: MarketsandMarkets™

Image
 The report " Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic)- Global Forecast to 2027", is projected to reach USD 3.7 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027). Browse in-depth TOC on " Bronchoscopy Market" 301- Tables 48- Figures 289- Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877 The growth in this market growth is largely driven by the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a major challenge to the growth of this market...
Read more